These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32867709)

  • 1. Raised CA19-9 and CEA have prognostic relevance in gallbladder carcinoma.
    Sachan A; Saluja SS; Nekarakanti PK; Nimisha ; Mahajan B; Nag HH; Mishra PK
    BMC Cancer; 2020 Aug; 20(1):826. PubMed ID: 32867709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of CA19-9 and CEA is associated with a poor prognosis in patients with resectable gallbladder carcinoma.
    Wen Z; Si A; Yang J; Yang P; Yang X; Liu H; Yan X; Li W; Zhang B
    HPB (Oxford); 2017 Nov; 19(11):951-956. PubMed ID: 28750922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Role of Preoperative Serum CA19-9 and Carcinoembryonic Antigen (CEA) Levels in Evaluating the Resectability of Advanced Gallbladder Cancer.
    Ma W; Li W; Wang J; Wu R; Liu C; Feng F; Jiang X
    Med Sci Monit; 2020 Sep; 26():e925017. PubMed ID: 32950997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
    Sun Z; Zhang N
    World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
    Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
    Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Marker Kinetics as Prognosticators in Patients with Unresectable Gallbladder Adenocarcinoma Undergoing Palliative Chemotherapy.
    Lee JW; Kim YT; Lee SH; Son JH; Kang JW; Ryu JK; Jang DK; Paik WH; Lee BS
    Gut Liver; 2018 Jan; 12(1):102-110. PubMed ID: 29069888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive value of systemic immune inflammation index for postoperative survival of gallbladder carcinoma patients.
    Chen H; Huang Z; Sun B; Wang A; Wang Y; Shi H; Zheng T; Li T; Huang M; Fu W
    J Surg Oncol; 2021 Jul; 124(1):59-66. PubMed ID: 33765331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of neutrophil-lymphocyte ratio and carbohydrate antigen 19-9 in patients with gallbladder carcinoma.
    Liu F; Hu HJ; Ma WJ; Yang Q; Wang JK; Li FY
    Medicine (Baltimore); 2019 Feb; 98(8):e14550. PubMed ID: 30813165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
    Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
    Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.
    Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J
    Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma.
    Yang Y; Huang X; Zhou L; Deng T; Ning T; Liu R; Zhang L; Bai M; Zhang H; Li H; Ba Y
    BMC Cancer; 2019 May; 19(1):526. PubMed ID: 31151431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer.
    Yin LK; Sun XQ; Mou DZ
    Asian Pac J Cancer Prev; 2015; 16(9):3867-70. PubMed ID: 25987051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of perineural invasion with clinicopathological factors and prognosis for curatively resected gallbladder carcinoma].
    Lei JJ; Zhang J; Chen C; Li Q; Su JB; Zhang D; Zhang R; Jin ZC; Geng ZM
    Zhonghua Wai Ke Za Zhi; 2022 Jul; 60(7):695-702. PubMed ID: 35775263
    [No Abstract]   [Full Text] [Related]  

  • 14. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
    Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
    Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer.
    Wang YF; Feng FL; Zhao XH; Ye ZX; Zeng HP; Li Z; Jiang XQ; Peng ZH
    World J Gastroenterol; 2014 Apr; 20(14):4085-92. PubMed ID: 24744600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of tumour markers CEA and CA19-9 improves the prognostic prediction in patients with pancreatic cancer.
    Reitz D; Gerger A; Seidel J; Kornprat P; Samonigg H; Stotz M; Szkandera J; Pichler M
    J Clin Pathol; 2015 Jun; 68(6):427-33. PubMed ID: 25759406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic values of anti-helicobacter pylori antibody combined with serum CA724, CA19-9, and CEA for young patients with early gastric cancer.
    Gong X; Zhang H
    J Clin Lab Anal; 2020 Jul; 34(7):e23268. PubMed ID: 32118318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating CEA-dNLR score predicts clinical outcome of metastatic gallbladder cancer patient.
    Du JH; Lu J
    J Clin Lab Anal; 2019 Feb; 33(2):e22684. PubMed ID: 30461064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomogram to predict overall survival after gallbladder cancer resection in China.
    Bai Y; Liu ZS; Xiong JP; Xu WY; Lin JZ; Long JY; Miao F; Huang HC; Wan XS; Zhao HT
    World J Gastroenterol; 2018 Dec; 24(45):5167-5178. PubMed ID: 30568393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of preoperative CA19-9 levels in evaluating resectability of gallbladder carcinoma.
    Liu F; Wang JK; Ma WJ; Yang Q; Hu HJ; Li FY
    ANZ J Surg; 2019 Mar; 89(3):E76-E80. PubMed ID: 30306702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.